Watching a dog constantly scratch, lick their paws raw, or chew at their skin is distressing for any pet owner. When basic flea prevention and soothing shampoos fail to break the cycle, veterinarians generally recommend one of two targeted allergy treatments: Cytopoint or Apoquel.
Both treatments target allergic itch (pruritus) and atopic dermatitis without the widespread hormonal side effects associated with traditional corticosteroids like prednisone. However, they accomplish this through completely different biological mechanisms, routes of administration, and safety profiles.
Deciding between Apoquel vs Cytopoint comes down to your dog’s specific health history, age, the underlying cause of the flare-up, and whether you prefer an at-home daily tablet or an in-clinic injection every four to eight weeks.
The Core Difference: How Cytopoint and Apoquel Work
While both therapies interrupt the itch-scratch cycle, they target different points in the neurological and immune pathways.
What Is Cytopoint?
Cytopoint (lokivetmab) is an injectable biological therapy—specifically, a canine monoclonal antibody (mAb). Monoclonal antibodies mimic the immune system’s natural antibodies.
Cytopoint circulates in the bloodstream and binds specifically to interleukin-31 (IL-31), a cytokine cytokine directly responsible for sending the itch signal from the skin to the brain. Because Cytopoint neutralizes IL-31 before it reaches peripheral nerve endings, the brain never receives the message to scratch. It is metabolized through normal protein breakdown pathways, avoiding processing by the liver and kidneys.
What Is Apoquel?
Apoquel (oclacitinib) is an oral synthetic medication categorized as a Janus kinase (JAK) inhibitor, specifically targeting the JAK-1 enzyme pathway.
When allergens trigger an immune reaction, several inflammatory cytokines (including IL-31, IL-2, IL-4, IL-6, and IL-13) bind to receptors on immune and nerve cells. This binding requires JAK enzymes to transmit the signal inward. Apoquel blocks JAK-1 enzymes from completing this signal transfer. By inhibiting the pathway inside the cell, Apoquel reduces both itching and associated allergic skin inflammation.
Direct Comparison: Cytopoint vs Apoquel
| Feature | Cytopoint (Lokivetmab) | Apoquel (Oclacitinib) |
| Drug Class | Canine monoclonal antibody | Janus kinase (JAK-1) inhibitor |
| Administration | Subcutaneous injection | Oral tablet or chewable |
| Dosing Frequency | Every 4 to 8 weeks (as needed) | Twice daily for up to 14 days, then once daily |
| Minimum Age | Safe for dogs of any age | 12 months of age or older |
| Onset of Relief | Typically within 24 hours | Typically within 4 to 12 hours |
| Organ Clearance | Degraded into amino acids (protein turnover) | Metabolized primarily by the liver |
| Primary Indication | Atopic and allergic dermatitis itch | Atopic and allergic dermatitis itch & inflammation |
| Concurrent Conditions | Safe with existing infections, organ disease | Caution with active severe infections, demodicosis, neoplasia |
Is Cytopoint Better Than Apoquel?
Neither medication is universally superior; whether Cytopoint is better than Apoquel depends entirely on your dog’s age, co-existing medical conditions, and lifestyle.
When Cytopoint Is Usually the Better Choice
- Dogs with liver, kidney, or systemic disease: Because Cytopoint is broken down by the body like natural dietary proteins rather than cleared through hepatic or renal pathways, it does not place metabolic stress on vital organs.
- Puppies under one year old: Cytopoint is approved for dogs of any age, making it the primary non-steroid option for young puppies suffering from severe early-onset allergies.
- Difficult-to-medicate dogs: If administering daily pills causes daily struggle or stress, an in-clinic injection provides consistent dosing without digestive battles.
- Dogs fighting active infections: Cytopoint neutralizes only the IL-31 cytokine without suppressing broader immune functions, meaning it does not hinder the body’s ability to clear bacterial or fungal skin infections.
When Apoquel Is Usually the Better Choice
- Acute, severe allergic flare-ups: Apoquel begins working rapidly, often offering noticeable relief within four to twelve hours. It is well-suited for sudden, short-lived reactions (such as seasonal pollen surges or flea bite sensitivity).
- Significant skin inflammation: Because Apoquel inhibits multiple cytokines in the JAK pathway, it helps reduce skin redness, swelling, and secondary inflammation more directly than Cytopoint, which strictly stops the itch signal.
- Flexible treatment schedules: If your dog only experiences flare-ups for two weeks during peak spring or autumn, Apoquel can be started and stopped on a veterinarian’s schedule without committing to a multi-week systemic injection.
- Need to avoid frequent vet visits: Pet owners who travel frequently or whose dogs experience severe clinic anxiety often prefer managing relief with tablets at home.
Side Effects and Safety Profiles
Understanding potential risks helps pet owners detect complications early and make informed choices with their veterinarian.
Cytopoint Safety
Because lokivetmab is a targeted biological therapy, adverse reactions are uncommon. Reported side effects include:
- Mild lethargy for 24 to 48 hours following the injection
- Transient soreness or mild swelling at the injection site
- Rare gastrointestinal upset (vomiting or diarrhea)
Over time, a small percentage of dogs may develop antibodies against the therapeutic antibody itself, which can gradually reduce its efficacy after repeated doses.
Apoquel Safety
Apoquel is generally well-tolerated, but because JAK enzymes play wider roles in cellular immune communication, safety guidelines are more stringent:
- Common short-term effects: Mild vomiting, diarrhea, decreased appetite, or lethargy, which often resolve as the dog adjusts to the medication.
- Infection susceptibility: Because it moderates immune signaling, Apoquel can worsen pre-existing infections. It should not be used in dogs with active systemic infections or demodicosis (mange).
- Neoplasia concerns: Apoquel is not recommended for dogs with a history of cancer, as modulating immune surveillance pathways may theoretically exacerbate certain neoplastic conditions.
- Age restrictions: It must not be given to dogs under 12 months of age, as early safety trials demonstrated an increased risk of severe infections and demodicosis in younger dogs.
Veterinarians frequently recommend baseline blood work (complete blood count and chemistry panel) before starting long-term, year-round Apoquel therapy, followed by routine annual or bi-annual monitoring.
Cytopoint vs Apoquel Cost Comparison
Treatment costs for both medications scale directly with your dog’s body weight. Neither medication has a low-cost generic alternative available in most markets, making long-term allergic dermatitis management an ongoing investment.
Estimating the Numbers (US & UK)
- Apoquel (Daily Tablets):
- United States: Typically ranges from $2.00 to $3.50 per tablet depending on strength (3.6 mg, 5.4 mg, or 16 mg). For a medium-to-large dog on a maintenance dose of one pill daily, expect to spend approximately $60 to $110 per month.
- United Kingdom: A month’s supply generally costs between £50 and £95, depending on the dog’s weight and dispensing fees.
- Cytopoint (Vials & Injections):
- United States: A single injection generally ranges from $65 to $160+, based on the number of vials required for your dog’s weight, plus any veterinary examination or technician administration fee. If the injection lasts 6 weeks, the annualized monthly cost is comparable to Apoquel.
- United Kingdom: Injections generally range from £55 to £130+ per session, varying by clinic pricing structures and dosing tiers.
Cost Considerations
- Small dogs (under 20 lbs / 9 kg): Cytopoint is often slightly cheaper or price-neutral compared to daily Apoquel, because low-dose vials are relatively affordable and last up to eight weeks in some patients.
- Large dogs (over 70 lbs / 32 kg): Apoquel is frequently more predictable and slightly less expensive month-to-month, as large dogs require multiple vials of Cytopoint per dose.
- Exam and injection fees: Some veterinary practices require a technician appointment fee or brief recheck examination to administer Cytopoint, which can increase the overall cost compared to filling an Apoquel prescription online or through a pharmacy.
Can You Use Cytopoint and Apoquel Together?
Yes. While many dogs do well on monotherapy, veterinarians sometimes combine both treatments during severe seasonal breakthroughs.
For example, a dog maintained on Cytopoint injections may experience a sudden acute flare-up due to a heavy pollen bloom or accidental allergen exposure. A veterinarian may prescribe a short, 7-to-14-day course of Apoquel to quickly suppress the intense inflammation while the systemic biological therapy continues to work. Because the two therapies function through different cellular pathways, they do not cross-react or neutralize one another.
Frequently Asked Questions
How fast do Cytopoint and Apoquel start working?
Apoquel is typically faster, often reducing itching within 4 to 12 hours after the first oral dose. Cytopoint generally begins providing noticeable relief within 24 hours of subcutaneous injection.
Can a dog switch from Apoquel to Cytopoint directly?
Yes. Because there is no cross-reactivity between a JAK inhibitor and an anti-IL-31 monoclonal antibody, switching usually requires no washout period. A veterinarian can administer Cytopoint while tapering or stopping Apoquel according to the dog’s individual response.
Why did Cytopoint stop working for my dog?
If Cytopoint loses effectiveness after several successful cycles, two main causes are common. First, the dog’s immune system may have developed neutralizing antibodies against the drug. Second, the dog may have developed a secondary bacterial or yeast skin infection; infections generate inflammation through pathways independent of IL-31, requiring targeted antimicrobial treatment rather than allergy medication alone.
Does Apoquel cause long-term organ damage?
Current long-term safety studies show that Apoquel does not commonly cause organ damage when used at standard maintenance doses (once daily). However, because it alters immune response signaling, periodic blood monitoring is standard practice to track white blood cell counts, liver values, and kidney function during ongoing therapy.
Making the Decision
Choosing between Cytopoint and Apoquel comes down to balancing medical context with everyday practicality:
- Choose Cytopoint if you prefer hassle-free administration every few weeks, have a puppy under one year old, or need a therapy that avoids liver and kidney metabolism.
- Choose Apoquel if you need rapid relief within hours, want the flexibility to start and stop treatment around short seasonal peaks, or prefer managing your dog’s care at home without clinic visits.
Work with your veterinarian to identify whether your dog’s symptoms are driven by environmental allergies, food sensitivities, or secondary infections. A comprehensive diagnostic plan ensures your dog receives targeted, lasting relief with minimal health trade-offs.
Sources & Clinical References
- Zoetis US: Apoquel (oclacitinib tablet) Prescribing Information and Safety Data.
- Zoetis US: Cytopoint (lokivetmab) Product Monograph and Mechanism of Action.
- Cosgrove, S. B., et al. (2013): Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. Veterinary Dermatology, 24(5), 479-e114.
- Moyaert, H., et al. (2017): A blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to a negative control in dogs with atopic dermatitis. Veterinary Dermatology, 28(6), 593-e145.